InsidersTradesSigma
CalciMedica, Inc.: directors' dealings · United States · SEC (Form 4)
Explore the full insider trade history of CalciMedica, Inc., a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €13.4m. The latest transaction was filed on 22 July 2025 (Acquisition). Among the most active insiders: Roberts Eric W. The full history is openly available.
68
Insider Decl.
0
Thresholds
€3m
54 ops.
Buy Volume
·
8 ops.
Sell Volume
47Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 22 July 2025
Declarations68 total
1,500 shares@ US$3.370.6% of flowCommon StockSEC:0001415889-25-020111:0
Ideal exit: 17 Apr 2026 (T+270)
2,500 shares@ US$2.471.1% of flowCommon StockSEC:0001415889-25-019816:0
Ideal exit: 10 Apr 2026 (T+270)
4,800 shares@ US$2.651.3% of flowCommon StockSEC:0001415889-24-028563:0
Ideal exit: 2 Sept 2025 (T+270)
3,000 shares@ US$2.681.1% of flowCommon StockSEC:0001415889-24-026280:0
Ideal exit: 11 Feb 2024 (T+270)
20,000 shares@ US$3.757.3% of flowCommon StockSEC:0001415889-24-026102:0
Ideal exit: 29 Jul 2025 (T+270)
86,867 shares@ US$3.75100.0% of flowCommon StockSEC:0001415889-24-026103:0
Ideal exit: 29 Jul 2025 (T+270)
53,333 shares@ US$3.7522.2% of flowCommon StockSEC:0001415889-24-025876:0
Ideal exit: 29 Jul 2025 (T+270)
53,333 shares@ US$3.7526.5% of flowCommon StockSEC:0001415889-24-025878:0
Ideal exit: 29 Jul 2025 (T+270)
20,000 shares@ US$3.7513.8% of flowCommon StockSEC:0001415889-24-025880:0
Ideal exit: 29 Jul 2025 (T+270)
11,761 shares@ US$1.39100.0% of flowCommon StockSEC:0001415889-24-023226:0
1,000 shares@ US$4.18980.8% of flowCommon StockSEC:0001415889-24-022361:0
Ideal exit: 24 May 2025 (T+270)
2,000 shares@ US$3.57850.9% of flowCommon StockSEC:0001415889-24-022243:0
Ideal exit: 20 May 2025 (T+270)
54,000 shares@ US$3.71921.8% of flowCommon StockSEC:0001415889-24-022242:0
Ideal exit: 20 May 2025 (T+270)
5,000 shares@ US$4.042.6% of flowCommon StockSEC:0001415889-24-022058:0
Ideal exit: 18 May 2025 (T+270)
51,278 shares@ US$3.5220.4% of flowCommon StockSEC:0001415889-24-018934:0
Ideal exit: 25 Mar 2025 (T+270)
8,443 shares@ US$3.2343.1% of flowCommon StockSEC:0001415889-24-018567:0
Ideal exit: 24 Mar 2025 (T+270)
5,000 shares@ US$3.222.2% of flowCommon StockSEC:0001415889-24-018496:0
Ideal exit: 24 Mar 2025 (T+270)
746 shares@ US$3.900.4% of flowCommon StockSEC:0001415889-24-009884:0
Ideal exit: 27 Dec 2024 (T+270)
91,086 shares@ US$4.266552.0% of flowCommon StockSEC:0001415889-24-002832:0
243,356 shares@ US$3.702100.0% of flowCommon StockSEC:0001415889-24-001830:0
Ideal exit: 19 Oct 2024 (T+270)
68,314 shares@ US$4.266532.4% of flowCommon StockSEC:0001415889-24-001829:0
91,086 shares@ US$4.266571.6% of flowCommon StockSEC:0001415889-24-001828:0
243,356 shares@ US$3.70288.0% of flowCommon StockSEC:0001415889-24-001831:0
Ideal exit: 19 Oct 2024 (T+270)
506 shares@ US$3.300.2% of flowCommon StockSEC:0001209191-23-058568:0
Ideal exit: 6 Sept 2024 (T+270)
2,400 shares@ US$3.121.0% of flowCommon StockSEC:0001209191-23-054769:0
Ideal exit: 2 Aug 2024 (T+270)
25 of 68 declarations